Fig. 41.1 Patient with symptomatic Dupuytren Disease, preoperative Fig. 41.2 Intraoperative placement of a sheet of acellular dermal matrix in wound bed following standard fasciectomy in the same patient from…
Fig. 17.1 Volar view after Dupuytren Disease of a digital cord of the fifth finger treated with collagenase of Clostridium histolyticum. A custom-made dorsal dynamic tension-free splint in thermoplastic material…
Fig. 23.1 59-year-old male, who had his first PNF at the age of 54 for right middle, ring and small MCP contractures (a, b, before the first PNF; c, d,…
Fig. 43.1 Results of PNF in patients with stage IV of Dupuytren contracture (group 1). (a) Left hand of a 72-year-old patient with Dupuytren contracture before and 21 days after…
Variable FSC (N = 48) CCH (N = 43) Age (mean + SD) 65.9 (9.2) 65.1 (9.7) Sex (male %) 83.3 88.4 Number of affected digits 64 50 Affected digits…
Fig. 22.1 Assessment of flexion deformity for rays and independent joint. α PED of MCP joint, β PED of PIP joint, α + β TPED of ray. TPED the total…
Fig. 3.1 Surgeon’s preferred choice of treatment depending on stage of disease LF is the favorite option, independent of the Tubiana stage. PNF is being chosen mainly in stages I…
Fig. 47.1 (a): Compression splint in 5th ray; (b) traction splint in 5th ray Fig. 47.2 Illustrative case of a satisfying result after 3 months of compression splinting. (a) Pretreatment,…
Fig. 48.1 Anatomic landmarks for CCH injection The site of injection is midway between the tip of the coracoid and the bicipital groove. Next, the safety and efficacy of injectable…
Fig. 7.1 Measurement of total extension deficit. Patients (n = 25) underwent fasciectomy for Dupuytren Disease. Total extension deficit was measured with a goniometer, with deficit from affected digits added…
